Variant report
Variant | esv3456895 |
---|---|
Chromosome Location | chr2:33924498-33926996 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:23)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:23 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CTCF | chr2:33925961-33926048 | Fibrobl | skin: | n/a | n/a |
2 | MYC | chr2:33926008-33926020 | MCF-7 | breast: | n/a | n/a |
3 | MYC | chr2:33925755-33925762 | MCF-7 | breast: | n/a | n/a |
4 | MYC | chr2:33925384-33925576 | MCF-7 | breast: | n/a | n/a |
5 | MYC | chr2:33925821-33926049 | MCF-7 | breast: | n/a | n/a |
6 | MYC | chr2:33925910-33926005 | MCF-7 | breast: | n/a | n/a |
7 | MYC | chr2:33925713-33925747 | MCF-7 | breast: | n/a | n/a |
8 | MYC | chr2:33925811-33925825 | MCF-7 | breast: | n/a | n/a |
9 | MYC | chr2:33925832-33925835 | MCF-7 | breast: | n/a | n/a |
10 | MYC | chr2:33925776-33925789 | MCF-7 | breast: | n/a | n/a |
11 | POLR2A | chr2:33926059-33926065 | MCF-7 | breast: | n/a | n/a |
12 | POLR2A | chr2:33925640-33925647 | MCF-7 | breast: | n/a | n/a |
13 | POLR2A | chr2:33926046-33926058 | MCF-7 | breast: | n/a | n/a |
14 | POLR2A | chr2:33925389-33925397 | MCF-7 | breast: | n/a | n/a |
15 | POLR2A | chr2:33925853-33926030 | MCF-7 | breast: | n/a | n/a |
16 | POLR2A | chr2:33925454-33925767 | Gliobla | brain: | n/a | n/a |
17 | POLR2A | chr2:33925402-33925496 | MCF-7 | breast: | n/a | n/a |
18 | POLR2A | chr2:33925372-33925575 | MCF-7 | breast: | n/a | n/a |
19 | POLR2A | chr2:33925692-33926044 | MCF-7 | breast: | n/a | n/a |
20 | POLR2A | chr2:33925584-33925602 | MCF-7 | breast: | n/a | n/a |
21 | POLR2A | chr2:33925669-33925690 | MCF-7 | breast: | n/a | n/a |
22 | POLR2A | chr2:33926033-33926044 | MCF-7 | breast: | n/a | n/a |
23 | POLR2A | chr2:33925262-33926027 | A549 | lung: | n/a | n/a |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr2:33926109..33928802-chr2:33930360..33932286,2 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000203386 | TF binding region |
ENSG00000203386 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs577522175 | chr2:33924506-33924507 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs539855882 | chr2:33924513-33924514 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs75256657 | chr2:33924525-33924526 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs534931343 | chr2:33924536-33924537 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs73927902 | chr2:33924584-33924585 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs144816435 | chr2:33924588-33924589 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs562832394 | chr2:33924601-33924602 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs562532309 | chr2:33924602-33924603 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs549164238 | chr2:33924623-33924624 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs73929503 | chr2:33924624-33924625 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs202102434 | chr2:33924637-33924638 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs200587693 | chr2:33924638-33924639 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs78449588 | chr2:33924639-33924640 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs66570147 | chr2:33924640-33924641 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs544332894 | chr2:33924645-33924646 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs564613658 | chr2:33924658-33924659 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs138690468 | chr2:33924668-33924669 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs372903365 | chr2:33924707-33924708 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs182276931 | chr2:33924708-33924709 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs566901685 | chr2:33924722-33924723 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs529597439 | chr2:33924728-33924729 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs186025479 | chr2:33924731-33924732 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs371218543 | chr2:33924732-33924733 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs72870939 | chr2:33924744-33924745 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs538439480 | chr2:33924750-33924751 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs189599830 | chr2:33924858-33924859 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs180793592 | chr2:33924875-33924876 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs571338751 | chr2:33924890-33924891 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs533666979 | chr2:33924924-33924925 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs185848545 | chr2:33924958-33924959 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs13013094 | chr2:33925009-33925010 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
32 | rs535573626 | chr2:33925049-33925050 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs12712350 | chr2:33925066-33925067 | Weak transcription | n/a | n/a | Overlapped CNVs | mRNA abundance |
34 | rs576116061 | chr2:33925100-33925101 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs190072644 | chr2:33925168-33925169 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs564397293 | chr2:33925187-33925188 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs140327646 | chr2:33925240-33925241 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs540765425 | chr2:33925248-33925249 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs114861636 | chr2:33925253-33925254 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs183044213 | chr2:33925309-33925310 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs549406630 | chr2:33925337-33925338 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs186850677 | chr2:33925350-33925351 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs531793569 | chr2:33925351-33925352 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs1868349 | chr2:33925363-33925364 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
45 | rs71447984 | chr2:33925371-33925372 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
46 | rs374979135 | chr2:33925402-33925403 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs145566909 | chr2:33925409-33925410 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs138067072 | chr2:33925424-33925425 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs192011162 | chr2:33925465-33925466 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs566921192 | chr2:33925473-33925474 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17393978 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Breast cancer | 17603634 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Prostate cancer | 18632612 | CNVD |
Bladder cancer | 21909424 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Autism | 22495311 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Leukemia | 18628472 | CNVD |
Autism | 19521722 | CNVD |
Autism | 18522746 | CNVD |
Breast cancer | 21364760 | CNVD |
Wilms tumour | 21544195 | CNVD |
Non-small cell lung cancer | 18927303 | CNVD |
Hereditary gingival fibromatosis | 19633868 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21785460 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 21045282 | CNVD |
Prostate cancer | 21965145 | CNVD |
Breast cancer | 16397240 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21508638 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Neurocytoma | 17123091 | CNVD |
Autism | 22495309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:33923000-33929200 | Weak transcription | H9 Cell Line | embryonic stem cell |
2 | chr2:33924800-33925000 | Enhancers | Right Ventricle | heart |
3 | chr2:33925000-33929400 | Weak transcription | Right Ventricle | heart |
4 | chr2:33925200-33925600 | Weak transcription | iPS DF 6.9 Cell Line | embryonic stem cell |
5 | chr2:33925600-33926000 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
6 | chr2:33925600-33926000 | ZNF genes & repeats | iPS DF 6.9 Cell Line | embryonic stem cell |
7 | chr2:33926000-33926200 | Weak transcription | iPS DF 6.9 Cell Line | embryonic stem cell |